Amendment to Distribution Agreement Between Heska Corporation, 3760 Rocky Mountain Ave., Loveland, CO 80538 (“Heska”) and Abbott Point of Care, Abbott Laboratories Inc. (“i-Stat”)Heska Corp • March 16th, 2009 • Biological products, (no disgnostic substances)
This Amendment shall amend the above-referenced Distribution Agreement dated 10/01/2004, as follows, where Heska purchases products and equipment for distribution from I-Stat (collectively referred to herein as “Agreement”) as set forth below.
AMENDMENT NO. 1 TO SUPPLY AND LICENSE AGREEMENTSupply and License Agreement • March 16th, 2009 • Heska Corp • Biological products, (no disgnostic substances)
This Amendment No. 1 modifies the Supply and License Agreement between Heska Corporation and Schering-Plough Animal Health Corporation, dated August 1, 2003 (“Original Agreement”).
SIXTH AMENDMENT TO THIRD AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENTCredit and Security Agreement • March 16th, 2009 • Heska Corp • Biological products, (no disgnostic substances)
This Amendment, dated as of December 30, 2008, is made by and between Heska Corporation, a Delaware corporation (“Heska”), Diamond Animal Health, Inc., an Iowa corporation (“Diamond”) (each of Heska and Diamond may be referred to herein individually as a “Borrower” and collectively as the “Borrowers”), and Wells Fargo Bank, National Association, operating through its Wells Fargo Business Credit operating division (the “Lender”).
HESKA CORPORATION 2003 EQUITY INCENTIVE PLANStock Option Agreement • March 16th, 2009 • Heska Corp • Biological products, (no disgnostic substances)
Tax Treatment This option is intended to be an incentive stock option under section 422 of the Internal Revenue Code or a nonstatutory option, as provided in the Notice of Stock Option Grant. To the extent this option is designated an incentive stock option and it does not qualify as an incentive stock option under applicable laws, it will be treated as a nonstatutory option.
July 7, 2004 Via Facsimile 858-646-8028 and Certified Mail Return Receipt Requested Quidel Corporation 10165 McKellar Court San Diego, CA 92121 Attention: Mark Paiz, Vice PresidentHeska Corp • March 16th, 2009 • Biological products, (no disgnostic substances)
This letter will confirm the agreement of Heska and Quidel to amend Section 10.1 of the Supply Agreement by adding the following proviso at the end of such Section 10.1:
